Article
Four companies receive approval to sell generic ofloxacin
The FDA in May approved an abbreviated new drug application for four companies to manufacture and sell a generic oxfloxacin ophthalmic solution 0.3% for the treatment of bacterial eye infections, including bacterial conjunctivitis and corneal ulcers.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
